Literature DB >> 25845388

The utility of measuring anti-Müllerian hormone in predicting menopause.

B Aydogan1, S Mirkin2.   

Abstract

Menopause is a relevant phase in a woman's reproductive life. Accurate estimation of the time of menopause could improve the preventive management of women's health. Reproductive hormones reflect the activity of follicle pools and provide information about ovarian aging. Anti-Mu llerian hormone (AMH) is secreted from small antral follicles and its level is correlated to the ovarian reserve. AMH declines with age, and data suggest that it can provide information on menopausal age and reproductive lifespan. Serum AMH levels become low approximately 5 years before the final menstrual period and are undetectable in postmenopausal women. The majority of studies indicate that AMH is relatively stable throughout the menstrual cycle; however, there are interindividual variabilites of serum AMH concentration under different conditions. AMH is an independent predictor of time to menopause. AMH coupled with age for menopause prediction provides stronger information than using age alone. Ongoing research is focused on constructing a multivariate model including AMH values, genes related to follicular recruitment and maternal age of menopause that would predict more precisily time to menopause.

Entities:  

Keywords:  ANTI-MÜLLERIAN HORMONE; MENOPAUSE; OVARIAN RESERVE

Mesh:

Substances:

Year:  2015        PMID: 25845388     DOI: 10.3109/13697137.2015.1036853

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  6 in total

Review 1.  Body composition and cardiometabolic health across the menopause transition.

Authors:  Kara L Marlatt; Dori R Pitynski-Miller; Kathleen M Gavin; Kerrie L Moreau; Edward L Melanson; Nanette Santoro; Wendy M Kohrt
Journal:  Obesity (Silver Spring)       Date:  2022-01       Impact factor: 5.002

2.  Anti-Mullerian Hormone as Predictor of Future and Ongoing Bone Loss During the Menopause Transition.

Authors:  Arun S Karlamangla; Albert Shieh; Gail A Greendale; Elaine W Yu; Sherri-Ann M Burnett-Bowie; Patrick M Sluss; Deborah Martin; Anthony Morrison; Joel S Finkelstein
Journal:  J Bone Miner Res       Date:  2022-04-04       Impact factor: 6.390

3.  Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.

Authors:  Kutluk H Oktay; Giuliano Bedoschi; Shari B Goldfarb; Enes Taylan; Shiny Titus; Glenn E Palomaki; Tessa Cigler; Mark Robson; Maura N Dickler
Journal:  Fertil Steril       Date:  2020-04-22       Impact factor: 7.329

4.  Longitudinal changes in reproductive hormones through the menopause transition in the Avon Longitudinal Study of Parents and Children (ALSPAC).

Authors:  Ana Goncalves Soares; Fanny Kilpi; Abigail Fraser; Scott M Nelson; Naveed Sattar; Paul I Welsh; Kate Tilling; Deborah A Lawlor
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

5.  Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone.

Authors:  Manuela Lotierzo; Victor Urbain; Anne-Marie Dupuy; Jean-Paul Cristol
Journal:  Pract Lab Med       Date:  2021-04-14

6.  Length of FMR1 repeat alleles within the normal range does not substantially affect the risk of early menopause.

Authors:  Katherine S Ruth; Claire E Bennett; Minouk J Schoemaker; Michael N Weedon; Anthony J Swerdlow; Anna Murray
Journal:  Hum Reprod       Date:  2016-09-09       Impact factor: 6.918

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.